EFFECT OF THYROID DYSFUNCTION ON BODY MASS INDEX AND HORMONAL IMBALANCE IN WOMEN HAVING POLYCYSTIC OVARIAN SYNDROME
DOI:
https://doi.org/10.54112/bcsrj.v2024i1.941Keywords:
Acne, Body Mass Index, Hirsutism, Polycystic Ovary Syndrome, Thyroid Dysfunction, Triiodothyronine, Thyroxine, Weight GainAbstract
Polycystic ovary syndrome (PCOS) is a prevalent gynecological disorder that significantly impacts women of reproductive age. Both PCOS and thyroid dysfunction independently increase the risk of ovarian dysfunction and prenatal complications. International studies have associated thyroid dysfunction with menstrual irregularities in women. Objective: This study aims to understand the influence of thyroid dysfunction on Body Mass Index (BMI) and hormonal imbalance in women diagnosed with PCOS. Methods: A cross-sectional study was conducted at two medical facilities, Sardar Begam Hospital and Cheema Family Hospital, involving participants aged 18 to 43 years. The sample size consisted of women diagnosed with PCOS. Data collection spanned from April 2023 to April 2024. A structured questionnaire was utilized to collect data on participants' history of PCOS, symptoms of irregular menstrual cycles, and BMI. Blood samples were collected to measure thyroid hormone levels, which were analyzed using ELISA. Statistical analysis was performed using [Insert Statistical Software], applying descriptive statistics and comparative analysis to assess the impact of thyroid dysfunction on BMI and hormone levels in PCOS patients. Results: The study findings indicate that 73.33% of women with both PCOS and thyroid dysfunction experienced weight gain, whereas only 26.67% did not report weight gain. Additionally, 80% of the participants reported acne, 60% experienced hirsutism, and 90% had irregular menstrual cycles. Muscle weakness and low energy were prevalent in 63.33% of the women, while 73.33% reported depression, and 66.67% reported hair loss. Significant differences were observed in the levels of Triiodothyronine (T3) and Thyroxine (T4) among women with PCOS with and without thyroid dysfunction. Specifically, for T3 levels, PCOS patients with thyroid dysfunction had a mean level of 7.3213, whereas those without thyroid dysfunction had a mean level of 63.812. Similarly, for T4 levels, PCOS patients with thyroid dysfunction had a mean level of 7.3213, compared to 63.812 in those without thyroid dysfunction. Conclusion: The study highlights the substantial impact of thyroid dysfunction on both T3 and T4 levels in PCOS patients. These findings underscore the importance of routine thyroid function screening in PCOS patients to devise more personalized and effective treatment strategies.
Downloads
References
Al-Suhaimi EA, Khan FA. Thyroid glands: Physiology and structure. Emerging concepts in endocrine structure and functions: Springer; 2022. p. 133-60.
Ali NH, Majeed AA. Thyroid hormone concentration and receptor. Egyptian Academic Journal of Biological Sciences, B Zoology. 2022;14(1):221-30.
Assi MH. Thyroid Gland Basics: A Comprehensive Review. Mustansiriya Medical Journal. 2023;22(2):172-81.
Bala R, Singh V, Rajender S, Singh K. Environment, lifestyle, and female infertility. Reproductive sciences. 2021;28:617-38.
Koyyada A, Orsu P. Role of hypothyroidism and associated pathways in pregnancy and infertility: Clinical insights. Tzu chi medical journal. 2020;32(4):312-7.
Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. Journal of healthcare engineering. 2022;2022(1):9240569.
Briden L, Shirin S, Prior JC. The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)—Evidence for treatment with cyclic progesterone. Drug Discovery Today: Disease Models. 2020;32:71-82.
Chaudhuri A. Polycystic ovary syndrome: Causes, symptoms, pathophysiology, and remedies. Obesity Medicine. 2023;39:100480.
Palomba S, Colombo C, Busnelli A, Caserta D, Vitale G. Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature. Frontiers in Endocrinology. 2023;14:1251866.
Gitsi E, Livadas S, Argyrakopoulou G. Nutritional and exercise interventions to improve conception in women suffering from obesity and distinct nosological entities. Frontiers in Endocrinology. 2024;15:1426542.
Babaniyi GG, Ajao BH, Akor UJ, Babaniyi E. Reproductive Endocrinology Drug Development: Hormones, Metabolism, and Fertility in Female Reproductive Health. Perspectives of Quorum Quenching in New Drug Development: CRC Press. p. 187-206.
Brown ED, Obeng-Gyasi B, Hall JE, Shekhar S. The thyroid hormone axis and female reproduction. International Journal of Molecular Sciences. 2023;24(12):9815.
Zia B, Nisar S, Ansari SZ. PCOS and Obesity: The Role of TSH on Fat Metabolism and Its Dysfunctional Repercussions. Obstetrics and Gynecology Advances. 2023:81.
Mukherjee P, Sanyal S, Chadha S, Mukherjee S. The impact of polycystic ovary syndrome (PCOS) on the risk of developing ovarian cancer and thyroid disorders: a comprehensive review. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2024;24(5):562-72.
Maqbool M, Ara I, Gani I. The story of polycystic ovarian syndrome: a challenging disorder with numerous consequences for females of reproductive age. International Journal of Current Research in Physiology and Pharmacology. 2022:19-31.
Ibrahim RO, Khorsheed TH, Bahram KA. Investigating Infertility Causes, Obesity Rates, and Mental Status of Infertile Females Attending the Infertility Center at Azadi Teaching Hospital in Kirkuk City, Iraq. Journal of Advances in Medical and Pharmaceutical Sciences. 2024;26(1):29-38.
Rashid N, Nigam A, Kauser S, Prakash P, Jain S, Wajid S. Assessment of insulin resistance and metabolic syndrome in young reproductive aged women with polycystic ovarian syndrome: analogy of surrogate indices. Archives of Physiology and Biochemistry. 2022;128(3):740-7.
Shanmugham D, Natarajan S, Karthik A. Prevalence of thyroid dysfunction in patients with polycystic ovarian syndrome: A cross sectional study. Int J Reprod Contracept Obstet Gynecol. 2018;7:3055-9.
Moustafa MM, Jamal MY, Al-Janabi RD. Thyroid hormonal changes among women with polycystic ovarian syndrome in Baghdad–a case-control study. F1000Research. 2019;8:669.
Sidra S, Tariq MH, Farrukh MJ, Mohsin M. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PloS one. 2019;14(10):e0223329.
Tagliaferri V, Romualdi D, Guido M, Mancini A, De Cicco S, Di Florio C, et al. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic–hyperinsulinaemic clamp study. European Journal of Endocrinology. 2016;175(5):433-41.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 F NADEEM, S ASHRAF, S ASLAM, A IQBAL, MA BUTT, R ANWAR, F IRSHAD
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.